The Effect Of Intraoperative Forced Air Warmer Use, On Postoperative Nausea And Vomiting

June 16, 2022 updated by: Mohammad Hamid, Aga Khan University

The Effect Of Intraoperative Forced Air Warmer Use, On Postoperative Nausea And Vomiting Among Laparoscopic Surgery Patients: A Randomized Controlled Trial

Intraoperative Hypothermia is a common problem, our object will be to evaluate the efficacy of forced air warmer (Model # eq-5000) for maintaining core body temperature in patients undergoing laparoscopic surgeries and its effect on postoperative nausea, vomiting and shivering.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

86

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients undergoing laparoscopic surgeries (Hernia Repair, Cholecystectomy, Appendectomy, Hysterectomy)
  • ASA Category I and II as per American Society of Anaesthesiologist Classification.
  • BMI< 35 kg/m2
  • Duration of surgery >1 hour and <3 hours
  • Patients who consent their participation

Exclusion Criteria:

  • Temperature >37.5oC or <35oC,
  • Chronic kidney disease
  • Heart failure
  • ASA Category 3&4 (American Society of Anaesthesiologist Classification)
  • Patients will be withdrawn from the group if their laparoscopy is converted to open surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: FAW and Bair Hugger Group
Group B, the intervention group (with FAW and Bair Hugger).
The EQUATOR™ (EQ-5000) air-warmer is a convective warmer, with the average and maximum Contact Surface Temperatures of 39℃ & 44℃ Respectively. Temperature on this device can be set at 36℃ , 40℃ , 44℃. The 3M™ Bair Hugger ™ (SW-2003) upper body blanket is used to warm the body from head till the xiphisternum
No Intervention: Control group
Group A, the control group (No FAW or Bair Hugger)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post Operative Nausea Vomiting Scale
Time Frame: Day 1

The scores of 0-3 will determine severity on the Post-operative nausea and vomiting scale.

0 - No nausea , No vomiting

  1. - Nausea present , No Vomiting
  2. - Nausea present , Vomiting present
  3. - Vomiting >2 episodes within 30 minutes
Day 1
Bedside Shivering Assessment Scale (BSAS)
Time Frame: Day 1

The scores of 0-3 will determine severity on Shivering

0 -(none) No shivering is detected on palpation of masseter, Neck, or chest muscles

  1. -(mild) Shivering localized to Neck and thorax only
  2. -(moderate) Shivering involves gross movement of the upper extremities( in addition to neck and thorax)
  3. -(severe) Shivering involves gross movements of the trunk and upper and lower extremities
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 1, 2022

Primary Completion (Anticipated)

October 1, 2023

Study Completion (Anticipated)

October 1, 2023

Study Registration Dates

First Submitted

June 10, 2022

First Submitted That Met QC Criteria

June 16, 2022

First Posted (Actual)

June 21, 2022

Study Record Updates

Last Update Posted (Actual)

June 21, 2022

Last Update Submitted That Met QC Criteria

June 16, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypothermia; Anesthesia

Clinical Trials on Bair hugger and Forces air warmer

Subscribe